WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

METHOD DEVELOPMENT AND VALIDATION REPORT FOR DETERMINATION OF N-NITROSO RANOLAZINE CONTENT IN RANOLAZINE PROLONGED RELEASE (PR) TABLETS 750 MG BY LC-MS/MS

Sanjeev Giri*

ABSTRACT

This work offers a novel method for determining several genotoxic contaminants in ranolazine active pharmaceutical ingredient (API) at the same time with a single LC-MS/MS method. Although the majority of the literature currently in publication concentrates on the identification of specific impurities, our approach provides a thorough solution for concurrent analysis, increasing productivity and efficiency in pharmaceutical manufacturing processes. Critical parameters, such as sensitivity, repeatability, linearity, recovery, and robustness, were determined by thorough experimentation and adherence to ICH standards to evaluate the process's performance. For each of the five contaminants, the calculated Limit of Detection (LOD) and Limit of Quantification (LOQ) values show remarkable sensitivity and accuracy, enabling the detection of minuscule quantities. All things considered, our proven approach shows excellent dependability and This work offers a novel method for determining several genotoxic contaminants in ranolazine active pharmaceutical ingredient (API) at the same time with a single LC-MS/MS method. Although the majority of the literature currently in publication concentrates on the identification of specific impurities, our approach provides a thorough solution for concurrent analysis, increasing productivity and efficiency in pharmaceutical manufacturing processes. Critical parameters, such as sensitivity, repeatability, linearity, recovery, and robustness, were determined by thorough experimentation and adherence to ICH standards to evaluate the process's performance. For each of the five contaminants, the calculated Limit of Detection (LOD) and Limit of Quantification (LOQ) values show remarkable sensitivity and accuracy, enabling the detection of minuscule quantities. All things considered, our proven approach shows excellent dependability and

Keywords: genotoxic impurities, LC-MS/MS, pharmaceutical manufacture, validation of methods, sensitivity, reproducibility, limit of quantification, limit of detection, and safety protocols.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More